Zobrazeno 1 - 10
of 17
pro vyhledávání: '"MESH: Vasoconstrictor Agents"'
Autor:
Narimane Al Kattani, Antoine Kimmoun, Chaojie Wei, Nicolas Dessales, Pierre-Yves Marie, Julie Delemazure, Bruno Levy, Huguette Louis, Khodor Issa
Publikováno v:
Critical Care Medicine
Critical Care Medicine, Lippincott, Williams & Wilkins, 2015, 43 (9), pp.e332-e340. ⟨10.1097/CCM.0000000000001078⟩
Critical Care Medicine, Lippincott, Williams & Wilkins, 2015, 43 (9), pp.e332-e340. ⟨10.1097/CCM.0000000000001078⟩
International audience; OBJECTIVE:Preliminary experimental data suggest that selective β1-blockers may improve ex vivo cardiac function in animal sepsis. Currently, the effects of esmolol on in vivo cardiac function and on vascular function are unkn
Autor:
Retailleau, Kevin, Toutain, Bertrand, Galmiche, Guillaume, Fassot, Celine, Sharif-Naeini, Reza, Kauffenstein, Gilles, Mericskay, Mathias, Duprat, Fabrice, Li, Linda, Mérot, Jean, Lardeux, Aurelie, Pizard, Anne, Baudrie, Véronique, Jeunemaitre, Xavier, Feil, Robert, Göthert, Joachim, Lacolley, Patrick, Henrion, Daniel, Li, Zhenlin, Loufrani, Laurent, Grimaud, L.
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2013, 33 (2), pp.339-346. ⟨10.1161/ATVBAHA.112.300708⟩
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2013, 33 (2), pp.339-346. 〈10.1161/ATVBAHA.112.300708〉
Arteriosclerosis, Thrombosis, and Vascular Biology, 2013, 33 (2), pp.339-346. ⟨10.1161/ATVBAHA.112.300708⟩
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2013, 33 (2), pp.339-346. ⟨10.1161/ATVBAHA.112.300708⟩
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2013, 33 (2), pp.339-346. 〈10.1161/ATVBAHA.112.300708〉
Arteriosclerosis, Thrombosis, and Vascular Biology, 2013, 33 (2), pp.339-346. ⟨10.1161/ATVBAHA.112.300708⟩
Objective— In resistance arteries, diameter adjustment in response to pressure changes depends on the vascular cytoskeleton integrity. Serum response factor (SRF) is a dispensable transcription factor for cellular growth, but its role remains unkno
Autor:
Carlos Labat, Soumaya El Moghrabi, Frederic Jaisser, Guillaume Galmiche, Ekaterina Belozertseva, Antoine Tarjus, Huguette Louis, Patrick Lacolley
Publikováno v:
Pflügers Archiv European Journal of Physiology
Pflügers Archiv European Journal of Physiology, Springer Verlag (Germany), 2015, 467 (8), pp.1643-1650. ⟨10.1007/s00424-014-1616-x⟩
Pflügers Archiv European Journal of Physiology, 2015, 467 (8), pp.1643-1650. ⟨10.1007/s00424-014-1616-x⟩
Pflügers Archiv European Journal of Physiology, Springer Verlag, 2015, 467 (8), pp.1643-1650. ⟨10.1007/s00424-014-1616-x⟩
Pflügers Archiv European Journal of Physiology, Springer Verlag (Germany), 2015, 467 (8), pp.1643-1650. ⟨10.1007/s00424-014-1616-x⟩
Pflügers Archiv European Journal of Physiology, 2015, 467 (8), pp.1643-1650. ⟨10.1007/s00424-014-1616-x⟩
Pflügers Archiv European Journal of Physiology, Springer Verlag, 2015, 467 (8), pp.1643-1650. ⟨10.1007/s00424-014-1616-x⟩
International audience; Identification of the mineralocorticoid receptor (MR) in the vasculature (i.e., endothelial and smooth muscle cells) raised the question of its role in vascular function and blood pressure control. Using a mouse model with con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a943ecb4b4a1866c851b0f0b5bd7a4a2
https://hal.univ-lorraine.fr/hal-01758570
https://hal.univ-lorraine.fr/hal-01758570
Autor:
Sonia Bergaya, Xavier Jeunemaitre, Juliette Hadchouel, Gervaise Loirand, Marc Rio, Jean-Michel Achard, Brigitte Escoubet, Daniel Henrion, Sébastien Faure, Véronique Baudrie, Philippe Bonnin
Publikováno v:
Hypertension
Hypertension, American Heart Association, 2011, 58 (3), pp.439-45. ⟨10.1161/HYPERTENSIONAHA.111.172429⟩
Hypertension, 2011, 58 (3), pp.439-45. ⟨10.1161/HYPERTENSIONAHA.111.172429⟩
Hypertension, American Heart Association, 2011, 58 (3), pp.439-45. 〈10.1161/HYPERTENSIONAHA.111.172429〉
Hypertension, American Heart Association, 2011, 58 (3), pp.439-45. ⟨10.1161/HYPERTENSIONAHA.111.172429⟩
Hypertension, 2011, 58 (3), pp.439-45. ⟨10.1161/HYPERTENSIONAHA.111.172429⟩
Hypertension, American Heart Association, 2011, 58 (3), pp.439-45. 〈10.1161/HYPERTENSIONAHA.111.172429〉
Gain-of-function mutations in the human WNK1 ( with-no-lysine[K]1 ) gene are responsible for a monogenic form of arterial hypertension, and WNK1 polymorphisms have been associated with common essential hypertension. The role of WNK1 in renal ionic re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5efd8ccb865359b39b8a6180b2bab09f
https://hal-unilim.archives-ouvertes.fr/hal-00945534
https://hal-unilim.archives-ouvertes.fr/hal-00945534
Autor:
Gervaise Loirand, Pierre Renard, Pierre Pacaud, Jérôme Leprince, David Chatenet, Hubert Vaudry, Marie-Christine Tonon, Christophe Dubessy, Elizabeth Scalbert, Bernard Calas, Céline Marionneau, Bruno Pfeiffer, Patricia Labarrère
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2003, 18 (2), pp.77-88. ⟨10.1080/1475636031000093507⟩
Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2003, 18 (2), pp.77-88. ⟨10.1080/1475636031000093507⟩
International audience; The sequence of human urotensin II (UII) has been recently established as H-Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val-OH, and it has been reported that UII is the most potent mammalian vasoconstrictor peptide identified so f
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2013, 75 (2), pp.423-30. ⟨10.1111/j.1365-2125.2012.04359.x⟩
British Journal of Clinical Pharmacology, 2013, 75 (2), pp.423-30. ⟨10.1111/j.1365-2125.2012.04359.x⟩
British Journal of Clinical Pharmacology, Wiley, 2013, 75 (2), pp.423-30. ⟨10.1111/j.1365-2125.2012.04359.x⟩
British Journal of Clinical Pharmacology, 2013, 75 (2), pp.423-30. ⟨10.1111/j.1365-2125.2012.04359.x⟩
International audience; AIMS: A single administration of hydrocortisone has been shown to enhance the pressor response to phenylephrine in healthy volunteers and to norepinephrine in septic shock patients. Similar data do not exist for fludrocortison
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7b3f80673b4b921d1612a86ffef1ae8f
https://hal.archives-ouvertes.fr/hal-00880010
https://hal.archives-ouvertes.fr/hal-00880010
Autor:
Zheng, Feng, Barthel, Grégoire, Collange, Olivier, Montémont, Chantal, Thornton, Simon, Longrois, Dan, Levy, Bruno, Audibert, Gérard, Malinovsky, Jean-Marc, Mertes, Paul-Michel
Publikováno v:
Critical Care Medicine
Critical Care Medicine, Lippincott, Williams & Wilkins, 2013, 41 (1), pp.195-204. ⟨10.1097/CCM.0b013e318267667b⟩
Critical Care Medicine, Lippincott, Williams & Wilkins, 2013, 41 (1), pp.195-204. ⟨10.1097/CCM.0b013e318267667b⟩
International audience; BACKGROUND:Severe hypotension resulting from anaphylactic shock may be refractory to epinephrine and impair cerebral oxygenation and metabolism contributing to anaphylactic shock morbidity and mortality. Refractoriness to epin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::65c798bf21d8c190e4128a732ad935b8
https://hal.univ-lorraine.fr/hal-01737699
https://hal.univ-lorraine.fr/hal-01737699
Autor:
Philippe Seguin, Yoann Launey, Jeff Morcet, Nicolas Nesseler, Yannick Mallédant, Jean-Vincent Frénel
Publikováno v:
Intensive Care Medicine
Intensive Care Medicine, Springer Verlag, 2012, 38 (10), pp.1718-22. ⟨10.1007/s00134-012-2659-0⟩
Intensive Care Medicine, 2012, 38 (10), pp.1718-22. ⟨10.1007/s00134-012-2659-0⟩
Intensive Care Medicine, Springer Verlag, 2012, 38 (10), pp.1718-22. ⟨10.1007/s00134-012-2659-0⟩
Intensive Care Medicine, 2012, 38 (10), pp.1718-22. ⟨10.1007/s00134-012-2659-0⟩
International audience; PURPOSE: Pulse oximetry (SpO(2)) measured at finger site via transmission mode may fail in situations of hypoperfusion. Forehead sensors using reflectance technology might be useful in these circumstances. We hypothesized that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b714334af6bd3bc62b92b47699586e28
https://www.hal.inserm.fr/inserm-00864861
https://www.hal.inserm.fr/inserm-00864861
Autor:
Etienne Roux, Patrick Brochard, Mireille Canal-Raffin, Arnaud Courtois, Thomas Ducret, Francelyne Marano, Christelle Guibert, Yannick Ladeiro, Françoise Rogerieux, Ghislaine Lacroix, Roger Marthan, Pascal Andujar, Bernard Muller, I. Baudrimont
Publikováno v:
Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology, Elsevier, 2010, 245 (2), pp.203-210. ⟨10.1016/j.taap.2010.03.002⟩
Toxicology and Applied Pharmacology, 2010, 245 (2), pp.203-10. ⟨10.1016/j.taap.2010.03.002⟩
Toxicology and Applied Pharmacology, Elsevier, 2010, 245 (2), pp.203-10. ⟨10.1016/j.taap.2010.03.002⟩
Toxicology and Applied Pharmacology, Elsevier, 2010, 245 (2), pp.203-210. ⟨10.1016/j.taap.2010.03.002⟩
Toxicology and Applied Pharmacology, 2010, 245 (2), pp.203-10. ⟨10.1016/j.taap.2010.03.002⟩
Toxicology and Applied Pharmacology, Elsevier, 2010, 245 (2), pp.203-10. ⟨10.1016/j.taap.2010.03.002⟩
International audience; Pulmonary circulation could be one of the primary vascular targets of finest particles that can deeply penetrate into the lungs after inhalation. We investigated the effects of engineered nanoparticles on vasomotor responses o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fce369ab619ac2e2181a3b3797c592
https://hal.archives-ouvertes.fr/hal-02439534
https://hal.archives-ouvertes.fr/hal-02439534
Autor:
Stephanie J. Frisbee, Elsa Isingrini, Phoebe A. Stapleton, Adam G. Goodwill, Alexandre d'Audiffret, Jefferson C. Frisbee
Publikováno v:
Journal of Applied Physiology
Journal of Applied Physiology, American Physiological Society, 2010, 108 (5), pp.1041-1051. ⟨10.1152/japplphysiol.01440.2009⟩
Journal of Applied Physiology, American Physiological Society, 2010, 108 (5), pp.1041-1051. ⟨10.1152/japplphysiol.01440.2009⟩
As chronic stress and depression have become recognized as significant risk factors for peripheral vascular disease in patients with no prior history of vasculopathy, we interrogated this relationship utilizing an established mouse model of chronic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b4fb04876d9d0f50d799352d91fdf7
https://hal.archives-ouvertes.fr/hal-03389557
https://hal.archives-ouvertes.fr/hal-03389557